Sritharan, Sruthi, Sivalingam, Nageswaran (2021) A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278. 119527pp. doi:10.1016/j.lfs.2021.119527
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | A comprehensive review on time-tested anticancer drug doxorubicin | ||
| Journal | Life Sciences | ||
| Authors | Sritharan, Sruthi | Author | |
| Sivalingam, Nageswaran | Author | ||
| Year | 2021 (August) | Volume | 278 |
| Publisher | Elsevier BV | ||
| DOI | doi:10.1016/j.lfs.2021.119527Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 13601708 | Long-form Identifier | mindat:1:5:13601708:2 |
| GUID | 0 | ||
| Full Reference | Sritharan, Sruthi, Sivalingam, Nageswaran (2021) A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278. 119527pp. doi:10.1016/j.lfs.2021.119527 | ||
| Plain Text | Sritharan, Sruthi, Sivalingam, Nageswaran (2021) A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278. 119527pp. doi:10.1016/j.lfs.2021.119527 | ||
| In | (2021) Life Sciences Vol. 278. Elsevier BV | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
